US20020185126A1 - Controlled gas-supply system - Google Patents

Controlled gas-supply system Download PDF

Info

Publication number
US20020185126A1
US20020185126A1 US09/341,975 US34197599A US2002185126A1 US 20020185126 A1 US20020185126 A1 US 20020185126A1 US 34197599 A US34197599 A US 34197599A US 2002185126 A1 US2002185126 A1 US 2002185126A1
Authority
US
United States
Prior art keywords
gas
metering
supply system
sensor
gas supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/341,975
Inventor
Christian Krebs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INO Therapeutics GmbH
Original Assignee
INO Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19701617A external-priority patent/DE19701617A1/en
Priority claimed from DE19746742A external-priority patent/DE19746742A1/en
Application filed by INO Therapeutics GmbH filed Critical INO Therapeutics GmbH
Assigned to INO THERAPEUTICS GMBH reassignment INO THERAPEUTICS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MESSER GRIESHEIM GMBH (NEW BY CHANGE OF NAME, MESSER AUSTRIA GMBH)
Publication of US20020185126A1 publication Critical patent/US20020185126A1/en
Assigned to INO THERAPEUTICS GMBH reassignment INO THERAPEUTICS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MESSER GRIESHEIM GMBH (NOW BY CHANGE OF NAME, MESSER AUSTRIA GMBH)
Priority to US10/737,431 priority Critical patent/US7861717B1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20Valves specially adapted to medical respiratory devices
    • A61M16/201Controlled valves
    • A61M16/202Controlled valves electrically actuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/105Filters
    • A61M16/106Filters in a path
    • A61M16/107Filters in a path in the inspiratory path
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0266Nitrogen (N)
    • A61M2202/0275Nitric oxide [NO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0291Xenon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/03Gases in liquid phase, e.g. cryogenic liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/14Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws

Definitions

  • the invention relates to an apparatus for the controlled metering of gases, in particular for the controlled addition of NO or oxygen to a respiratory gas in apparatus for artificial respiration or respiratory donation.
  • Artificial respiration apparatus are used for mechanical artificial respiration, for anesthesia and for respiratory therapy by treatment with gases, e.g. oxygen donation or treatment with nitrogen monoxide (NO).
  • gases e.g. oxygen donation or treatment with nitrogen monoxide (NO).
  • An inhalation-anesthesia apparatus is described, for example, in DE 37 12 598 A1. It is used to meter anesthetic gas into the respiratory gas.
  • DE 43 25 319 C1 describes an apparatus for continuously metering NO to the respiratory air of patients, containing a respirator, an NO metering vessel, a metering unit with control unit and an analyser for determining the NO concentration in the respiratory air.
  • the control unit (monitoring and regulating unit) is responsible for metering the NO to be metered by determining the volumetric flow rates of respiratory gas and NO, taking into account the NO analysis parameter.
  • the NO metering is proportional to volume or to volumetric flow rate, so that the NO concentration in the respiratory gas is always kept constant.
  • the essential technical principles involved in metering NO in NO therapy are described in: “C. Krebs et al., Technological basis for NO application and environmental security, Acta Anaesthesiologica Scandinavica Supplement 109, Vol. 40, 1996; pp. 84-87”.
  • the gases are administered either via so-called nasal spectacles or a nasal probe (nasal application: in the most simple case, a gas supply tube, the opening of which is arranged to be open beneath the nasal orifices of the patient) or by means of a breathing mask (particularly in the case of CPAP).
  • a pulse-oxymeter is used to adapt the respiratory gas volume to be fed to the patient to the blood gas saturation level determined.
  • the invention is based on the object of providing an apparatus for supplying patients with one or more gases, the gas metering into a respiratory gas being individually adapted to a patient by means of a control unit of the apparatus.
  • the object is achieved by means of a program-controlled or a program- and sensor-controlled gas supply system, in particular by means of a gas supply system with controlled metering of at least one gas, in which system the gas is a pure gas or a gas mixture, the gas is metered in an inspiration-synchronized, program-controlled and/or sensor-controlled manner, and the volume of gas metered in one respiratory cycle is dependent on the respiratory gas volume.
  • Gas supply systems are arrangements or devices which feed one or more gases to a patient or provide one or more gases to a patient for respiration.
  • the gases in particular medical gases, are preferably mixed with air, a respiratory gas or oxygen, so that gas mixtures which maintain respiration are obtained.
  • a gas supply system is, for example, an artificial respiration system comprising artificial respiration apparatus and gas metering device for one or more gases.
  • An artificial respiration system comprises, for example, hose connections or gas lines, gas source, gas metering device (gas metering unit), breathing mask, preferably a respiratory gas humidifier and, if appropriate, one or more gas filters (e.g. NO 2 filter).
  • Artificial respiration systems having an artificial respiration apparatus are generally used for the in-patient treatment of patients.
  • Gas-supply systems may be stationary or mobile, in particular portable, apparatus.
  • Gas supply systems according to the invention are preferably used to treat humans or mammals with one or more gases, in particular for inhalation treatment of the lungs.
  • Gas supply systems are, for example, also gas-donating apparatus for spontaneously breathing patients. Such a gas supply system is described in DE 43 09 923 A1, to which reference is made.
  • the gas supply system generally contains a breathing mask or nasal spectacles.
  • the gas supply system preferably contains a humidifier for the respiratory gas and/or gas.
  • the gas supply system preferably contains one or more gas sources.
  • Gas sources are, for example, compressed-gas sources containing a compressed gas, such as compressed-gas vessels, compressed-gas cylinders, pressure boxes, compressed-gas lines or vessels containing cold-liquefied gas (e.g. for delivering evaporated, gaseous oxygen).
  • a gas generator may also serve as a gas source.
  • a gas generator is, for example, an on-site gas generator, e.g. for producing nitrogen monoxide (NO), in particular NO in nitrogen, by low discharge in a nitrogen/oxygen gas mixture.
  • Further gas generators are, for example, electrolysis cells (e.g. for generating hydrogen) or chemical reactors (e.g. reaction chambers in which chemical reactions take place in order to generate gas).
  • the gases are preferably medical gases.
  • Medical gases are gases or gas mixtures which are used in the medical sector, for example for treating disorders; therapy, prophylaxis, anesthesia, diagnostics, improving the respiratory function or state of health of humans or mammals. Medical gases often have a pharmacological action. However, medical gases may also be used for other properties (e.g. as contrast agents for tomography, in particular NMR computer tomography of the lung or other image-generating procedures). Medical gases are, for example, oxygen, anesthetic gases such as laughing gas (N 2 O) or xenon, hydrogen, noble gases such as helium, carbon dioxide (CO 2 ), nitrogen monoxide (NO) or gas mixtures containing one or more of the abovementioned gases as a constituent, e.g.
  • helium/oxygen gas mixtures helium/oxygen/NO gas mixtures or helium/oxygen/CO 2 gas mixtures.
  • the individual components or individual components and partial gas mixtures may also be metered in parallel (simultaneously or at different times) to, for example, a respiratory gas.
  • Medical gases generally have a high purity.
  • the metering of one or more gases advantageously takes place only during inspiration phases. No gas metering takes place during expiration. Gas metering which is synchronized to the respiratory cycles is achieved by means of a trigger effect with the aid of a sensor. The start of inspiration or the start and end of inspiration is detected by a control unit on the basis of sensor measured values. Gas metering takes place continuously (e.g. with a fixed volume or concentration of the metered gas per inspiration over the entire operating time) or discontinuously (e.g. with metering breaks), preferably
  • This type of gas metering is referred to as pulse-modulated gas metering.
  • the duration t max of inspiration and the beginning and end of inspiration are advantageously determined by means of a sensor.
  • the pulse width t i is less than or equal to the duration t max .
  • the values of pulse width, pulse height and number of pulses within one inspiration may be fixed in advance or variable.
  • a gas is advantageously metered by the combination of a basic metering, preferably with constant settings for V i ′, n i and t i , and an additive metering with variable (controlled) settings of V i ′, n i and t i .
  • Basic metering and additive metering of a gas are preferably carried out using separate metering devices (e.g. controlled solenoid valves).
  • the basic metering may in this case provide a basic supply of a gas and the gas volume and gas concentration are regulated by the additive gas metering.
  • the additive gas metering may be program- or sensor-controlled.
  • Measured values from the preceding inspiration e.g. the duration of inspiration (t max ) and/or the respiratory gas volume (V ges ), are used to control the metering of a gas.
  • Controlled variables are, for example, the gas concentration C i or the mixing ratio of gases (e.g. V 1 /V 2 ).
  • the gas metering can be varied between a lower limit value and an upper limit value, e.g. the gas concentration can be increased and reduced over a series of inspirations (e.g. in a regular sequence with an even or uneven ratio of raising and lowering the gas concentration; advantageous for NO metering).
  • the gas metering may also advantageously be controlled on the basis of a response curve previously determined on the patient.
  • a sensor is used to measure a body parameter of the patient (e.g. oxygen saturation in the peripheral blood and/or heart rate, determined by means of pulse-oxymeter) as a function of the metered volume of gas or gas concentration, and the temporal gas demand required to establish a uniform body condition is determined.
  • the sequence of the program used to control the metering of a gas is dependent on certain measured variables, which are detected by one or more sensors, being reached. For example, if a measured variable falls below or exceeds a threshold, program sequences of the gas metering may be triggered.
  • One threshold may activate a program section which brings about a metering sequence for high, average or low gas metering.
  • the gas metering is advantageously a metered addition of the gas (e.g. oxygen or NO or NO-containing gas) to the respiratory gas in metering intervals of a defined sequence (sequential gas metering).
  • the gas metering is carried out, for example, via a repeating sequence of inspiration cycles with gas metered to the respiratory gas (gas metering) and inspiration cycles without gas being added (exclusion).
  • the sequential gas metering is, for example, a repetition of the following sequences (regular sequences) with an equal duration of the metering intervals (e.g. metered addition of oxygen or NO during artificial respiration or for spontaneously breathing patients):
  • a metered gas addition may also comprise variable (irregular) sequences, e.g. a succession of sequences with increasing or decreasing numbers of metered gas additions.
  • the sequential gas metering has the advantage that for a time high levels of gas can be metered, while nevertheless on average, over a period of time, a very low concentration or volume of gas is added.
  • a sequence of one or more (two, three, four, five, six, seven, eight, nine, ten or more) inspirations can be used to administer a standard NO dose (e.g.
  • a sequence of inspirations one, two, three, four, five, six, seven, eight, nine, ten or twenty, thirty, forty, fifty or more inspirations
  • a sequence of inspirations one, two, three, four, five, six, seven, eight, nine, ten or twenty, thirty, forty, fifty or more inspirations
  • the sequential gas metering of two, three or more gases can be combined.
  • the controlled gas metering leads to a lower consumption of gas, in particular to a lower overall volume of gas administered, so that side-effects from the gas (e.g. NO) on the patient can be reduced.
  • a further advantage is that discontinuation and withdrawal of the gas therapy (e.g. NO therapy) are made easier. It is generally advantageous when withdrawing artificially respirated patients who need NO to continuously reduce the amount of NO administered.
  • a further significant advantage is that the level of toxic NO 2 formed overall from NO in the artificial respiration is lower.
  • Control equipment for gas metering can advantageously be controlled electrically.
  • Control equipment used is, for example, time- and/or sensor-controlled solenoid valves (e.g. solenoid valve with upstream-connected electronics, sold by Burkert, Germany), mass throughput regulators (e.g. appliance type MFC from Brooks, the Netherlands), automatically adjustable pressure regulators (e.g. adjustable by means of stepper motor or electric motor) or control valves for the direct, in particular automatic, adjustment of the gas pressure.
  • solenoid valves e.g. solenoid valve with upstream-connected electronics, sold by Burkert, Germany
  • mass throughput regulators e.g. appliance type MFC from Brooks, the Netherlands
  • automatically adjustable pressure regulators e.g. adjustable by means of stepper motor or electric motor
  • control valves for the direct, in particular automatic, adjustment of the gas pressure.
  • the evaporation of the gas is advantageously regulated by means of a heating device in the storage vessel.
  • the heating device is preferably an electrical resistance heater
  • Sensors are generally measurement sensors.
  • the term also comprises (in a broad sense) measurement appliances and analysis devices.
  • the use of sensors can be divided into sensors for triggering the gas metering (trigger sensors), sensors for controlling the sequence of gas metering (regulating sensors) and sensors for monitoring the safety of the gas supply system (e.g. for triggering an alarm or for safety shut-off of apparatus functions, in particular by means of gas sensors).
  • a suitable trigger sensor is a pressure sensor which measures the gas pressure, in particular a low-pressure sensor.
  • the measured signal from the sensor can itself be used as a control signal (e.g. in the case of a so-called “smart sensor”) or can be converted into a control signal by means of an electronic processing and control unit.
  • the sensor may, for example, measure the pressure (gas pressure) in or in front of the nose (e.g. by means of a sensor which is integrated in the breathing mask or nasal spectacles).
  • a pressure sensor is also suitable for detecting the profile of the inspirational reduced pressure and can be used to control a gas metering which is adapted to requirements (e.g. higher gas metering for deep inspirations, lower gas metering for shallow inspiration). It is also possible to measure differential pressures and use these for control purposes (e.g. differential pressure with respect to pressure at corresponding phase of preceding inspiration), since at a defined setting these pressures indicate the square of the flow rate.
  • Regulating sensors are, for example, pressure sensors, gas-specific sensors or gas sensors (e.g. electrochemical gas sensors for O 2 , NO or NO 2 ) and, in particular, sensors for detecting physical reactions, body functions or body states of the patient (patient-oriented measured values), sensors for measuring the oxygen saturation in the peripheral blood, e.g. pulse-oxymeters (e.g. ASAT appliance from Baxter, USA), sensors for blood gas analysis (e.g. 995 HO appliance from AVL, Austria; “Perotrend” appliance from Crosstec), sensors for measuring blood pressure or sensors for measuring pulmonary blood pressure (also pulmonary pressure or pulmonary artery pressure; by means of a catheter floating in the pulmonary artery, e.g.
  • gas-specific sensors or gas sensors e.g. electrochemical gas sensors for O 2 , NO or NO 2
  • sensors for detecting physical reactions, body functions or body states of the patient patient-oriented measured values
  • sensors for measuring the oxygen saturation in the peripheral blood e.g. pulse-oxymeters (e.g.
  • Heart rate and oxygen saturation in the peripheral blood can be measured by means of pulse-oxymeters.
  • the simultaneous detection of both parameters is advantageously used to control the gas metering, e.g. when metering oxygen and/or NO in artificial respiration systems or systems for spontaneously breathing patients, in particular in the gas therapy of COPD patients.
  • sensors in particular pressure sensors
  • the sensor may also be arranged at a distance from the actual measurement site, e.g. may be positioned in the metering line, or may be connected to the measurement site by means of a suitable hose line.
  • vacuum measurement apparatus pressure measuring apparatus
  • sensors measurement apparatus, analysis apparatus
  • concentration of a gas component e.g. NO concentration, carbon dioxide concentration or oxygen concentration.
  • the NO metering is advantageously controlled using a curve indicating the response of the patient to NO.
  • the response curve of the patient is determined in advance, i.e. the temporal dependence of a measured variable (a parameter) on the quantity or concentration of NO administered.
  • the response curve may, for example, be determined by measuring the increasing oxygen content in the peripheral blood which is brought about by the NO metering and/or by the pulmonary pressure, which falls during NO metering. This response curve can be used to determine the most suitable NO metering.
  • An empirically determined set value can be compared with the measured variable in order to control the NO metering and, on this basis, a control unit (e.g. flow regulator or solenoid valve) can be actuated, the NO quantity, for example, being controlled in such a way that the temporal change in the measured variable measured on-line comes closer to the response curve.
  • a control unit e.g. flow regulator or solenoid valve
  • Limit values for the NO concentration to be set (minimum, maximum concentration), number of respiratory cycles with and without metered addition and optimum parameters for controlling the gas metering can be determined in a preceding determination or during the therapy itself (determination of the control parameters: desired gas concentration profile over the course of time).
  • the following procedure can be used to optimize the NO metering (automatic detection and adaptation of the most favorable (minimum required) NO quantity): 1.
  • Constant increase in quantity of NO (NO increase) from lower limit (e.g. 0.1 ppm NO) to upper limit (e.g. 100 ppm), involving measuring the oxygen saturation in the peripheral blood and/or the pulmonary pressure (observing the reaction of the patient response).
  • Determining the appropriate NO concentration (becomes set value for control) .
  • the optimum NO profile (NO concentration curve in the respiratory gas) is achieved when a constant oxygen saturation in the peripheral blood or a minimum, constant pulmonary pressure is established (adaptive control of gas metering).
  • the gas supply system is used, for example, in the treatment of hypoxia or high lung pressure with NO. It is also advantageously used for the following disorders/clinical pictures: ARDS (Adult Respiratory Distress Syndrome), asthma, PPH (Primary Pulmonary Hypertension), COPD (Chronic Obstructive Pulmonary Disorder), heart malformation, immature lungs in the case of premature and newborn infants.
  • ARDS Adult Respiratory Distress Syndrome
  • asthma PPH (Primary Pulmonary Hypertension)
  • COPD Choronic Obstructive Pulmonary Disorder
  • heart malformation immature lungs in the case of premature and newborn infants.
  • discontinuous measurement methods for determining the oxygenation in the circulation can be used as measured and regulating variables, e.g. by means of the HO 995 apparatus from AVL (Austria), or alternatively continuous measurement methods, e.g. using the “Perotrend” appliance from Crosstec, can be used.
  • Blood gas analysis generally determines arterial blood gas, venous blood gas or mixed-venous blood gas.
  • the gas supply system for automatic oxygen metering in oxygen therapy is advantageously suitable for use in both spontaneously breathing and artificially respirated patients.
  • pulse-modulated metering of oxygen or other additional gases is advantageously controlled on the basis of measured variables such as blood oxygen content and/or pulmonary blood pressure or blood oxygen content and/or heart rate.
  • Program control for the oxygen metering and, if appropriate, further metered gases allows a gas supply system to have a particularly simple design, in particular to be a portable gas supply system for chronically ill patients (e.g. COPD patients).
  • the gas supply system is particularly advantageously suited to controlled, adapted gas metering of two or more gases, e.g. selected from the gases NO, oxygen, hydrogen gas, helium and carbon dioxide.
  • the controlled metering of helium is used to improve the airing of the lungs, while carbon dioxide stimulates respiration.
  • a sensor control system and/or a program control system may be provided for each gas.
  • Two or more gases can be metered on the basis of the determination of overall volumetric flow rate or partial volumetric flow rates of the individual gases.
  • the gases can be metered in the same way as one individual gas is metered.
  • a mutually adapted metering of the gases is preferred.
  • the gas mixing ratio may be selected as a control parameter.
  • the respiratory gas for pulse-modulated gas metering, in particular for metering two or more gases, it is important for the respiratory gas to be as homogeneously mixed as possible, in order to avoid concentration peaks of a gas in the respiratory gas. It is advantageous to homogenize the gas mixture by means of a mixing body in the hose system, preferably in the respiratory tube.
  • a mixing body in the hose system, preferably in the respiratory tube.
  • a hollow-cylindrical part which has a helically twisted part (e.g. metal strip or plastic strip with ends rotated through 180° with respect to one another) is fitted in the tube system as the mixing body.
  • the mixing path is both for tube systems used in the intensive care sector (22 mm tube diameter for artificial respiration of adults, 15 mm for children, 10 mm for newborn infants) and, for example, for 8 mm or 10 mm tube systems for home therapy of the chronically ill, in particular COPD patients.
  • Filters, absorbers or humidifiers e.g. in a respiratory tube, also improve the homogenous mixing of gases.
  • a filter for nitrogen dioxide (NO 2 ) e.g. filters containing polyphenylene sulfide as filter material or sodium carbonate cartridges (Sodalime). It is also advantageously possible to combine an on-site generator for NO with a NO 2 filter.
  • NO 2 nitrogen dioxide
  • FIG. 1 diagrammatically shows a breathing mask 2 with sensor 1 (e.g. pressure sensor) and gas supply tube 3 (e.g. oxygen) as parts of a gas supply system.
  • sensor 1 e.g. pressure sensor
  • gas supply tube 3 e.g. oxygen
  • FIG. 2 diagrammatically shows nasal spectacles 4 with sensor 1 (e.g. pressure sensor) and gas supply tube 3 (e.g. oxygen).
  • sensor 1 e.g. pressure sensor
  • gas supply tube 3 e.g. oxygen
  • a plurality of nasal spectacles 4 may be arranged on the patient in order to supply the patient with different gases.
  • coaxial tubes in which a different gas flows through each lumen.
  • FIG. 3 shows a schematic diagram of the nasal pressure P N as a function of time t without gas metering, measured by means of a pressure sensor in front of the nasal orifice.
  • the marks a and b indicate the start and end of an inspiration interval.
  • FIG. 4 shows a schematic diagram of the measured nasal pressure P N as a function of time t when metering oxygen.
  • the bottom diagram shows the volumetric flow rate of metered oxygen in the metering interval a to b (inspiration interval).
  • FIG. 5 shows a schematic diagram of the measured nasal pressure P N as a function of time t with pulsed metering of oxygen.
  • the bottom diagram shows the volumetric flow rate of pulsed, metered oxygen in the metering interval a to b (inspiration interval).
  • FIG. 6 diagrammatically shows a sensor-controlled gas supply system with a plurality of sensors 1 (P 1 : pressure), 1 ′ (P 2 : pressure) and 1 ′′ (T: temperature) and a gas source 7 (e.g. oxygen) .
  • a gas source 7 e.g. oxygen
  • the pressure of the gas e.g. oxygen
  • the diameter of one or possibly more nozzles 5 or constrictions may also, for example, be the diameter of the valve inlet or valve seat
  • the temperature temperature sensor
  • determine the volumetric flow rate by means of a pressure/temperature back-calculation for the precise standard volumetric flow rate.
  • the trigger of the start of the inspiration phase and hence the beginning of opening of the solenoid valve can be triggered by the low-pressure sensor P 2 .
  • the duration of opening and therefore the volume to be administered is displayed or adjusted by means of a volume assigned to a potentiometer on the control unit 6 (or by input/display of a more highly electronicized system, such as for example microprocessor/controller).
  • FIG. 7 diagrammatically shows a gas supply system with pressure-reducing device at the gas source 7 .
  • this may be a compressed-gas vessel with pressure-reducing device or a liquefied-gas vessel with evaporation device, with or without pressure-reducing device, the volumetric flow rate can be altered. This is detected by means of the pressure measurement and the new time or the new volume administered can be displayed and calculated/controlled.
  • FIG. 8 diagrammatically shows the profile of the total volumetric flow rate analogously to the nasal pressure P N (bottom diagram) when metering a plurality of gases with the respective volumetric flow rates V 1 , V 2 , V n .
  • a suitable gas supply system is shown in FIG. 11.
  • FIG. 9 shows the profile of volumetric flow rates produced for various gases.
  • FIGS. 8 and 9 are examples of different mixing ratios produced for a plurality of gases.
  • FIG. 10 diagrammatically shows a gas supply system with a plurality of gas sources 7 , 7 ′ and 7 ′′ and assigned pressure sensors 1 , 1 ′ and 1 ′′.
  • FIG. 11 diagrammatically shows a gas metering system with a plurality of gas sources 7 , 7 ′ and 7 ′′ and associated pressure-reducing devices (e.g. nozzles) 5 , 5 ′ and 5 ′′ and a sensor 1 for controlling the solenoid valves by means of a control unit 6 .
  • a gas metering system with a plurality of gas sources 7 , 7 ′ and 7 ′′ and associated pressure-reducing devices (e.g. nozzles) 5 , 5 ′ and 5 ′′ and a sensor 1 for controlling the solenoid valves by means of a control unit 6 .
  • FIG. 12 shows the delivery of gas from the gas sources 7 (e.g. oxygen) and 7 ′ (e.g. NO source) via a sensor 1 and/or a gas analysis unit.
  • gas sources 7 e.g. oxygen
  • 7 ′ e.g. NO source
  • FIG. 13 shows a gas supply system with a plurality of gas sources 7 to 7 ′′′ (e.g. oxygen, NO source, helium, carbon dioxide) using sensors 1 to 1 ′′′ and patient-mounted sensor 1 IV and filter element 9 .
  • gas sources 7 to 7 ′′′ e.g. oxygen, NO source, helium, carbon dioxide
  • FIG. 14 diagrammatically shows a gas supply system for liquid oxygen and NO-containing gas.
  • the valves V 1 and V 2 e.g. solenoid valves
  • the patient-mounted sensor 1 e.g. pressure sensor
  • FIG. 15 diagrammatically shows the temporal profile of volumetric flow rates of oxygen and NO-containing gas and of the measured nasal pressure P N .
  • FIG. 16 shows a mixing device for gases, comprising hollow-cylindrical part 11 and mixing body 10 , which is formed by a twisted flat body (e.g. made from metal, plastic or glass; ends of the flat body rotated with respect to one another, e.g. 180° or 360°).
  • the mixing device as mixing path, is preferably fitted in the respiratory tube of the gas supply system.
  • a portable unit for the combined metering of oxygen and NO contains a storage vessel for cold-liquefied oxygen with integrated evaporation system (capacity: 0.5 liters), a compressed-gas vessel for NO-nitrogen gas mixture (typically 800 to 1000 ppm NO in N 2 ; geometric cylinder volume: 0.2 to 1.0 liter; filling pressure: 150 to 200 bar), a control unit for controlling the metering of oxygen and NO gas mixture, at least 2 electrically controllable solenoid valves, gas hoses and nasal spectacles with pressure sensor, NO sensor and NO 2 sensor in the respiratory gas line, a warning system and safety device (alarm: when NO gas mixture cylinder empty, when oxygen storage vessel empty, excessive oxygen, NO or NO 2 concentration in the respiratory gas).
  • the pressure sensor is used to trigger the gas metering (inspiration-synchronized gas metering).
  • the solenoid valve for oxygen metering and the solenoid valve for NO gas mixture metering are opened.
  • a set oxygen volumetric flow rate V O2 ′ of 3000 ml/minute results in a pulse width t O2 of 1 second.
  • the NO gas mixture contains 1000 ppm NO.
  • the preset NO gas mixture volumetric flow rate V NO ′ amounts to 500 ml/minute.
  • V NO (V O2 *C NO )/(F ⁇ C NO ).
  • V O2 3000 ml
  • V NO 1.8 ml
  • V NO ′ 500 ml/minute.
  • it is advantageous for the metering conditions to be selected in such a way that the NO metering time is t NO 1 ⁇ 2t O2 . This is achieved by reducing the volumetric flow rate V NO ′ by lowering the preliminary pressure in the gas metering line.
  • the preliminary gas pressure is advantageously reduced by means of a controllable diaphragm or nozzle incorporated in the gas metering line (automatic adjustment of the diaphragm aperture or nozzle aperture).
  • the calculation example contains only one predetermined NO concentration. It is preferable for the NO concentration to be varied by means of a control program or a sensor control system.

Abstract

The invention relates to a gas-supply system for patients receiving artificial respiration or breathing spontaneously, in which one or several gases (for example NO, oxygen) are added to the respiration gas at varying proportions (continuously or intermittently) by means of a control device (program control, sensor control or combined program/sensor control). This gas-supply system allows for adaptive dosing of the gas to suit individual patients.

Description

  • The invention relates to an apparatus for the controlled metering of gases, in particular for the controlled addition of NO or oxygen to a respiratory gas in apparatus for artificial respiration or respiratory donation. [0001]
  • Artificial respiration apparatus are used for mechanical artificial respiration, for anesthesia and for respiratory therapy by treatment with gases, e.g. oxygen donation or treatment with nitrogen monoxide (NO). [0002]
  • An inhalation-anesthesia apparatus is described, for example, in DE 37 12 598 A1. It is used to meter anesthetic gas into the respiratory gas. [0003]
  • DE 43 25 319 C1 describes an apparatus for continuously metering NO to the respiratory air of patients, containing a respirator, an NO metering vessel, a metering unit with control unit and an analyser for determining the NO concentration in the respiratory air. The control unit (monitoring and regulating unit) is responsible for metering the NO to be metered by determining the volumetric flow rates of respiratory gas and NO, taking into account the NO analysis parameter. The NO metering is proportional to volume or to volumetric flow rate, so that the NO concentration in the respiratory gas is always kept constant. The essential technical principles involved in metering NO in NO therapy are described in: “C. Krebs et al., Technological basis for NO application and environmental security, Acta Anaesthesiologica Scandinavica Supplement 109, Vol. 40, 1996; pp. 84-87”. [0004]
  • Patients with chronic breathing difficulties (e.g. asthma and COPD (Chronic Obstructive Pulmonary Disease)) are assisted by a generally movable oxygen donor in the oxygen supply to the body. Such patients are referred to as spontaneously breathing patients, in contrast to patients who are connected to an artificial respiration apparatus by in-patient intubation. Thus, spontaneously breathing patients are given, for example, an additional oxygen donation (LOT=Long-term Oxygen Therapy) or respiratory assistance (via CPAP=Continuous Positive Airways Pressure). The gases are administered either via so-called nasal spectacles or a nasal probe (nasal application: in the most simple case, a gas supply tube, the opening of which is arranged to be open beneath the nasal orifices of the patient) or by means of a breathing mask (particularly in the case of CPAP). [0005]
  • An apparatus for feeding respiratory gas or oxygen to a patient is described in DE 43 09 923 A1. A pulse-oxymeter is used to adapt the respiratory gas volume to be fed to the patient to the blood gas saturation level determined. [0006]
  • The invention is based on the object of providing an apparatus for supplying patients with one or more gases, the gas metering into a respiratory gas being individually adapted to a patient by means of a control unit of the apparatus. [0007]
  • The object is achieved by means of a program-controlled or a program- and sensor-controlled gas supply system, in particular by means of a gas supply system with controlled metering of at least one gas, in which system the gas is a pure gas or a gas mixture, the gas is metered in an inspiration-synchronized, program-controlled and/or sensor-controlled manner, and the volume of gas metered in one respiratory cycle is dependent on the respiratory gas volume. [0008]
  • Gas supply systems are arrangements or devices which feed one or more gases to a patient or provide one or more gases to a patient for respiration. The gases, in particular medical gases, are preferably mixed with air, a respiratory gas or oxygen, so that gas mixtures which maintain respiration are obtained. A gas supply system is, for example, an artificial respiration system comprising artificial respiration apparatus and gas metering device for one or more gases. An artificial respiration system comprises, for example, hose connections or gas lines, gas source, gas metering device (gas metering unit), breathing mask, preferably a respiratory gas humidifier and, if appropriate, one or more gas filters (e.g. NO[0009] 2 filter). Artificial respiration systems having an artificial respiration apparatus are generally used for the in-patient treatment of patients. Gas-supply systems may be stationary or mobile, in particular portable, apparatus. Gas supply systems according to the invention are preferably used to treat humans or mammals with one or more gases, in particular for inhalation treatment of the lungs.
  • An artificial respiration system which, with modifications, can be used as a gas supply system is described, for example, in DE 43 25 319 C1, to which reference is made. [0010]
  • Gas supply systems are, for example, also gas-donating apparatus for spontaneously breathing patients. Such a gas supply system is described in DE 43 09 923 A1, to which reference is made. [0011]
  • The gas supply system generally contains a breathing mask or nasal spectacles. The gas supply system preferably contains a humidifier for the respiratory gas and/or gas. [0012]
  • The gas supply system preferably contains one or more gas sources. Gas sources are, for example, compressed-gas sources containing a compressed gas, such as compressed-gas vessels, compressed-gas cylinders, pressure boxes, compressed-gas lines or vessels containing cold-liquefied gas (e.g. for delivering evaporated, gaseous oxygen). A gas generator may also serve as a gas source. A gas generator is, for example, an on-site gas generator, e.g. for producing nitrogen monoxide (NO), in particular NO in nitrogen, by low discharge in a nitrogen/oxygen gas mixture. Further gas generators are, for example, electrolysis cells (e.g. for generating hydrogen) or chemical reactors (e.g. reaction chambers in which chemical reactions take place in order to generate gas). The gases are preferably medical gases. Medical gases are gases or gas mixtures which are used in the medical sector, for example for treating disorders; therapy, prophylaxis, anesthesia, diagnostics, improving the respiratory function or state of health of humans or mammals. Medical gases often have a pharmacological action. However, medical gases may also be used for other properties (e.g. as contrast agents for tomography, in particular NMR computer tomography of the lung or other image-generating procedures). Medical gases are, for example, oxygen, anesthetic gases such as laughing gas (N[0013] 2O) or xenon, hydrogen, noble gases such as helium, carbon dioxide (CO2), nitrogen monoxide (NO) or gas mixtures containing one or more of the abovementioned gases as a constituent, e.g. helium/oxygen gas mixtures, helium/oxygen/NO gas mixtures or helium/oxygen/CO2 gas mixtures. As an alternative to metering a gas mixture, the individual components or individual components and partial gas mixtures may also be metered in parallel (simultaneously or at different times) to, for example, a respiratory gas. Medical gases generally have a high purity.
  • The metering of one or more gases advantageously takes place only during inspiration phases. No gas metering takes place during expiration. Gas metering which is synchronized to the respiratory cycles is achieved by means of a trigger effect with the aid of a sensor. The start of inspiration or the start and end of inspiration is detected by a control unit on the basis of sensor measured values. Gas metering takes place continuously (e.g. with a fixed volume or concentration of the metered gas per inspiration over the entire operating time) or discontinuously (e.g. with metering breaks), preferably [0014]
  • a) program-controlled (e.g. time program), [0015]
  • b) sensor-controlled, or [0016]
  • c) with a combined program control and sensor control. [0017]
  • The control unit (e.g. microprocessor control, computer control) receives the measurement signal from the sensor for triggering the gas metering and preferably uses a program and/or sensor control to determine whether the gas is metered, and for what duration (pulse width ti), at what volumetric flow rate V[0018] i′ (differential change in the gas volume Vi with respect to time t: Vi′=dVi/dt=pulse height) and with what number ni of metering operations (ni: number of pulses) the gas i is metered. This type of gas metering is referred to as pulse-modulated gas metering. The duration tmax of inspiration and the beginning and end of inspiration are advantageously determined by means of a sensor. The pulse width ti is less than or equal to the duration tmax. The metered gas volume Vi of a pulse is calculated on the basis of the equation Vi=Vi′*ti, and the volume of gas metered during an inspiration is calculated on the basis of the equation Vi=Vi′*ti*ni.
  • The concentration C[0019] i of a metered gas, based on the respiratory gas volume Vges (Vges=sum of all the gas volumes Vi), can be calculated, given ni=1, according to the equation Ci=Vi/Vges=Vi′*ti/Vges.
  • The values of pulse width, pulse height and number of pulses within one inspiration may be fixed in advance or variable. [0020]
  • In many applications, a gas is advantageously metered by the combination of a basic metering, preferably with constant settings for V[0021] i′, ni and ti, and an additive metering with variable (controlled) settings of Vi′, ni and ti. Basic metering and additive metering of a gas are preferably carried out using separate metering devices (e.g. controlled solenoid valves). The basic metering may in this case provide a basic supply of a gas and the gas volume and gas concentration are regulated by the additive gas metering. In this case, the additive gas metering may be program- or sensor-controlled.
  • Measured values from the preceding inspiration, e.g. the duration of inspiration (t[0022] max) and/or the respiratory gas volume (Vges), are used to control the metering of a gas. Controlled variables are, for example, the gas concentration Ci or the mixing ratio of gases (e.g. V1/V2).
  • By means of a program, the gas metering can be varied between a lower limit value and an upper limit value, e.g. the gas concentration can be increased and reduced over a series of inspirations (e.g. in a regular sequence with an even or uneven ratio of raising and lowering the gas concentration; advantageous for NO metering). The gas metering may also advantageously be controlled on the basis of a response curve previously determined on the patient. To determine the response curve, a sensor is used to measure a body parameter of the patient (e.g. oxygen saturation in the peripheral blood and/or heart rate, determined by means of pulse-oxymeter) as a function of the metered volume of gas or gas concentration, and the temporal gas demand required to establish a uniform body condition is determined. [0023]
  • In a further process variant of the gas metering, the sequence of the program used to control the metering of a gas is dependent on certain measured variables, which are detected by one or more sensors, being reached. For example, if a measured variable falls below or exceeds a threshold, program sequences of the gas metering may be triggered. One threshold may activate a program section which brings about a metering sequence for high, average or low gas metering. [0024]
  • The gas metering is advantageously a metered addition of the gas (e.g. oxygen or NO or NO-containing gas) to the respiratory gas in metering intervals of a defined sequence (sequential gas metering). Thus, the gas metering is carried out, for example, via a repeating sequence of inspiration cycles with gas metered to the respiratory gas (gas metering) and inspiration cycles without gas being added (exclusion). [0025]
  • The sequential gas metering is, for example, a repetition of the following sequences (regular sequences) with an equal duration of the metering intervals (e.g. metered addition of oxygen or NO during artificial respiration or for spontaneously breathing patients): [0026]
  • a) one metered gas addition and one exclusion, [0027]
  • b) 2 metered gas additions (e.g. 2 inspiration phases with metered gas addition) and 25 following exclusions (i.e. 25 following inspiration phases without metered gas addition), [0028]
  • c) 10 metered gas additions and 30 following exclusions, or [0029]
  • d) 3 metered gas additions and 80 following exclusions. [0030]
  • A metered gas addition may also comprise variable (irregular) sequences, e.g. a succession of sequences with increasing or decreasing numbers of metered gas additions. [0031]
  • The most simple sequence is the sequence comprising one metered gas addition and one exclusion. The repetition of the sequence provides the overall cycle of metering steps (of gas metering) . Examples of different forms of sequential gas metering are listed in the table. [0032]
    Forms of sequential gas metering (where ni = 1)
    Gas
    concentration or
    gas volume in Duration of Sequence of
    Type of the metering the metering the metering
    metering interval interval intervals
    1. Constant Constant Constant
    2. Constant Constant Variable
    3. Constant Variable Constant
    4. Constant Variable Variable
    5. Variable Variable Constant
    6. Variable Constant Variable
    7. Variable Constant Constant
    8. Variable Variable variable
  • The sequential gas metering has the advantage that for a time high levels of gas can be metered, while nevertheless on average, over a period of time, a very low concentration or volume of gas is added. For example, a sequence of one or more (two, three, four, five, six, seven, eight, nine, ten or more) inspirations can be used to administer a standard NO dose (e.g. up to 80 ppm NO in the respiratory gas for extremely severe pulmonary failure), and then a sequence of inspirations (one, two, three, four, five, six, seven, eight, nine, ten or twenty, thirty, forty, fifty or more inspirations) can be used to administer a very low quantity of NO, so that the result is an average NO concentration which lies, for example, in the ppb or ppt range. The sequential gas metering of two, three or more gases can be combined. [0033]
  • The controlled gas metering leads to a lower consumption of gas, in particular to a lower overall volume of gas administered, so that side-effects from the gas (e.g. NO) on the patient can be reduced. A further advantage is that discontinuation and withdrawal of the gas therapy (e.g. NO therapy) are made easier. It is generally advantageous when withdrawing artificially respirated patients who need NO to continuously reduce the amount of NO administered. When using an artificial respiration system with controlled NO metering, a further significant advantage is that the level of toxic NO[0034] 2 formed overall from NO in the artificial respiration is lower.
  • Control equipment for gas metering can advantageously be controlled electrically. Control equipment used is, for example, time- and/or sensor-controlled solenoid valves (e.g. solenoid valve with upstream-connected electronics, sold by Burkert, Germany), mass throughput regulators (e.g. appliance type MFC from Brooks, the Netherlands), automatically adjustable pressure regulators (e.g. adjustable by means of stepper motor or electric motor) or control valves for the direct, in particular automatic, adjustment of the gas pressure. In the case of gas sources containing cold-liquefied gas, the evaporation of the gas is advantageously regulated by means of a heating device in the storage vessel. The heating device is preferably an electrical resistance heater which is controlled by switching the heating current on or off or by continuously varying the heating output. In addition, the gas can be metered by means of a solenoid valve in the gas supply line. [0035]
  • Sensors are generally measurement sensors. The term also comprises (in a broad sense) measurement appliances and analysis devices. The use of sensors can be divided into sensors for triggering the gas metering (trigger sensors), sensors for controlling the sequence of gas metering (regulating sensors) and sensors for monitoring the safety of the gas supply system (e.g. for triggering an alarm or for safety shut-off of apparatus functions, in particular by means of gas sensors). [0036]
  • A suitable trigger sensor is a pressure sensor which measures the gas pressure, in particular a low-pressure sensor. The measured signal from the sensor can itself be used as a control signal (e.g. in the case of a so-called “smart sensor”) or can be converted into a control signal by means of an electronic processing and control unit. The sensor may, for example, measure the pressure (gas pressure) in or in front of the nose (e.g. by means of a sensor which is integrated in the breathing mask or nasal spectacles). A pressure sensor is also suitable for detecting the profile of the inspirational reduced pressure and can be used to control a gas metering which is adapted to requirements (e.g. higher gas metering for deep inspirations, lower gas metering for shallow inspiration). It is also possible to measure differential pressures and use these for control purposes (e.g. differential pressure with respect to pressure at corresponding phase of preceding inspiration), since at a defined setting these pressures indicate the square of the flow rate. [0037]
  • Regulating sensors are, for example, pressure sensors, gas-specific sensors or gas sensors (e.g. electrochemical gas sensors for O[0038] 2, NO or NO2) and, in particular, sensors for detecting physical reactions, body functions or body states of the patient (patient-oriented measured values), sensors for measuring the oxygen saturation in the peripheral blood, e.g. pulse-oxymeters (e.g. ASAT appliance from Baxter, USA), sensors for blood gas analysis (e.g. 995 HO appliance from AVL, Austria; “Perotrend” appliance from Crosstec), sensors for measuring blood pressure or sensors for measuring pulmonary blood pressure (also pulmonary pressure or pulmonary artery pressure; by means of a catheter floating in the pulmonary artery, e.g. type SWAN-Ganz from Baxter, USA, with electrical conversion by means of the “Explorer” appliance from Baxter), sensors for measuring the cardiac output or cardiac rate or sensors for detecting artificial respiration parameters, such as artificial respiration pressure, artificial respiration volume or compliance (expansibility of the lung).
  • Heart rate and oxygen saturation in the peripheral blood can be measured by means of pulse-oxymeters. The simultaneous detection of both parameters is advantageously used to control the gas metering, e.g. when metering oxygen and/or NO in artificial respiration systems or systems for spontaneously breathing patients, in particular in the gas therapy of COPD patients. [0039]
  • Preferably, highly miniaturized sensors (in particular pressure sensors), which allow positioning directly at the measurement site (e.g. on the nose, on or in the patient's body) are used. However, the sensor may also be arranged at a distance from the actual measurement site, e.g. may be positioned in the metering line, or may be connected to the measurement site by means of a suitable hose line. This may, for example, be the case when vacuum measurement apparatus (pressure measuring apparatus) are used as sensors or in the case of sensors (measurement apparatus, analysis apparatus) for determining the concentration of a gas component, e.g. NO concentration, carbon dioxide concentration or oxygen concentration. It is also possible to combine different sensors in order to control the gas metering and/or gas mixture. For example, it is possible to use a combination of pressure sensors and gas sensors. [0040]
  • The use of the sensors allows automatic, patient-oriented gas metering. [0041]
  • The invention is explained below on the basis of NO metering, oxygen therapy and the combined metering of NO-containing gas and oxygen. [0042]
  • The NO metering is advantageously controlled using a curve indicating the response of the patient to NO. The response curve of the patient is determined in advance, i.e. the temporal dependence of a measured variable (a parameter) on the quantity or concentration of NO administered. The response curve may, for example, be determined by measuring the increasing oxygen content in the peripheral blood which is brought about by the NO metering and/or by the pulmonary pressure, which falls during NO metering. This response curve can be used to determine the most suitable NO metering. An empirically determined set value can be compared with the measured variable in order to control the NO metering and, on this basis, a control unit (e.g. flow regulator or solenoid valve) can be actuated, the NO quantity, for example, being controlled in such a way that the temporal change in the measured variable measured on-line comes closer to the response curve. [0043]
  • Limit values for the NO concentration to be set (minimum, maximum concentration), number of respiratory cycles with and without metered addition and optimum parameters for controlling the gas metering can be determined in a preceding determination or during the therapy itself (determination of the control parameters: desired gas concentration profile over the course of time). The following procedure can be used to optimize the NO metering (automatic detection and adaptation of the most favorable (minimum required) NO quantity): 1. Constant increase in quantity of NO (NO increase) from lower limit (e.g. 0.1 ppm NO) to upper limit (e.g. 100 ppm), involving measuring the oxygen saturation in the peripheral blood and/or the pulmonary pressure (observing the reaction of the patient=response). Determining the appropriate NO concentration (becomes set value for control) . Monitoring the set value by means of second response measurement (passing through the NO concentration lower limit/upper limit/lower limit=triangular measurement). The optimum NO profile (NO concentration curve in the respiratory gas) is achieved when a constant oxygen saturation in the peripheral blood or a minimum, constant pulmonary pressure is established (adaptive control of gas metering). [0044]
  • The gas supply system is used, for example, in the treatment of hypoxia or high lung pressure with NO. It is also advantageously used for the following disorders/clinical pictures: ARDS (Adult Respiratory Distress Syndrome), asthma, PPH (Primary Pulmonary Hypertension), COPD (Chronic Obstructive Pulmonary Disorder), heart malformation, immature lungs in the case of premature and newborn infants. [0045]
  • In the case of gas supply systems for oxygen therapy, it is advantageous to use the measurement of the oxygen saturation of hemoglobin in the peripheral blood (e.g. measurement by means of a pulse-oxymeter). The oxygen concentration in the respiratory gas or the oxygen volume is controlled. The control range of the oxygen concentration extends to up to 100% by volume. In the same way as for the NO metered addition, in this procedure for which the gas supply system is being used the metered addition of oxygen is regulated in a controlled manner. [0046]
  • In oxygen therapy, discontinuous measurement methods for determining the oxygenation in the circulation can be used as measured and regulating variables, e.g. by means of the HO 995 apparatus from AVL (Austria), or alternatively continuous measurement methods, e.g. using the “Perotrend” appliance from Crosstec, can be used. Blood gas analysis generally determines arterial blood gas, venous blood gas or mixed-venous blood gas. [0047]
  • The gas supply system for automatic oxygen metering in oxygen therapy is advantageously suitable for use in both spontaneously breathing and artificially respirated patients. In particular, pulse-modulated metering of oxygen or other additional gases is advantageously controlled on the basis of measured variables such as blood oxygen content and/or pulmonary blood pressure or blood oxygen content and/or heart rate. [0048]
  • Program control for the oxygen metering and, if appropriate, further metered gases allows a gas supply system to have a particularly simple design, in particular to be a portable gas supply system for chronically ill patients (e.g. COPD patients). [0049]
  • The gas supply system is particularly advantageously suited to controlled, adapted gas metering of two or more gases, e.g. selected from the gases NO, oxygen, hydrogen gas, helium and carbon dioxide. The controlled metering of helium is used to improve the airing of the lungs, while carbon dioxide stimulates respiration. A sensor control system and/or a program control system may be provided for each gas. Two or more gases can be metered on the basis of the determination of overall volumetric flow rate or partial volumetric flow rates of the individual gases. In principle, the gases can be metered in the same way as one individual gas is metered. A mutually adapted metering of the gases is preferred. For example, the gas mixing ratio may be selected as a control parameter. When metering a plurality of gases, it is, of course, possible to use different control types for the individual gases, e.g. to control some of the gases using a sensor control unit and some using a program control unit or some using a combined program/sensor control unit. By suitably selecting one or more gas sources (e.g. liquid oxygen, NO-containing gas, in particular NO-containing gas from an on-site generator) and providing a suitable control unit, the power required to operate the gas supply system can be considerably reduced (advantageous for battery-operated mobile systems). [0050]
  • For pulse-modulated gas metering, in particular for metering two or more gases, it is important for the respiratory gas to be as homogeneously mixed as possible, in order to avoid concentration peaks of a gas in the respiratory gas. It is advantageous to homogenize the gas mixture by means of a mixing body in the hose system, preferably in the respiratory tube. Preferably, a hollow-cylindrical part which has a helically twisted part (e.g. metal strip or plastic strip with ends rotated through 180° with respect to one another) is fitted in the tube system as the mixing body. [0051]
  • The mixing path is both for tube systems used in the intensive care sector (22 mm tube diameter for artificial respiration of adults, 15 mm for children, 10 mm for newborn infants) and, for example, for 8 mm or 10 mm tube systems for home therapy of the chronically ill, in particular COPD patients. [0052]
  • Filters, absorbers or humidifiers, e.g. in a respiratory tube, also improve the homogenous mixing of gases. [0053]
  • Use on patients for NO application, e.g. for the chronically ill, is improved by fitting a filter for nitrogen dioxide (NO[0054] 2), e.g. filters containing polyphenylene sulfide as filter material or sodium carbonate cartridges (Sodalime). It is also advantageously possible to combine an on-site generator for NO with a NO2 filter.
  • The following figures explain the invention and describe gas supply systems for spontaneously breathing patients (e.g. COPD patients). [0055]
  • FIG. 1 diagrammatically shows a [0056] breathing mask 2 with sensor 1 (e.g. pressure sensor) and gas supply tube 3 (e.g. oxygen) as parts of a gas supply system.
  • FIG. 2 diagrammatically shows nasal spectacles [0057] 4 with sensor 1 (e.g. pressure sensor) and gas supply tube 3 (e.g. oxygen). A plurality of nasal spectacles 4 may be arranged on the patient in order to supply the patient with different gases. As an alternative to a plurality of nasal spectacles, it is also possible to use coaxial tubes, in which a different gas flows through each lumen.
  • FIG. 3 shows a schematic diagram of the nasal pressure P[0058] N as a function of time t without gas metering, measured by means of a pressure sensor in front of the nasal orifice. The marks a and b indicate the start and end of an inspiration interval.
  • FIG. 4 shows a schematic diagram of the measured nasal pressure P[0059] N as a function of time t when metering oxygen. The bottom diagram (figure) shows the volumetric flow rate of metered oxygen in the metering interval a to b (inspiration interval).
  • FIG. 5 shows a schematic diagram of the measured nasal pressure P[0060] N as a function of time t with pulsed metering of oxygen. The bottom diagram (figure) shows the volumetric flow rate of pulsed, metered oxygen in the metering interval a to b (inspiration interval).
  • FIG. 6 diagrammatically shows a sensor-controlled gas supply system with a plurality of sensors [0061] 1 (P1: pressure), 1′ (P2: pressure) and 1″ (T: temperature) and a gas source 7 (e.g. oxygen) . If the pressure of the gas (e.g. oxygen) is known either from a one-off or a continuous measurement of the pressure (P1) and of the diameter of one or possibly more nozzles 5 or constrictions (may also, for example, be the diameter of the valve inlet or valve seat), it is thus possible to determine on a one-off or continuous basis the volumetric flow administered to the patient and, if the duration is known, to determine the volume of gas administered. It is also possible, by means of the temperature (temperature sensor), to determine the volumetric flow rate by means of a pressure/temperature back-calculation for the precise standard volumetric flow rate. The trigger of the start of the inspiration phase and hence the beginning of opening of the solenoid valve can be triggered by the low-pressure sensor P2. The duration of opening and therefore the volume to be administered is displayed or adjusted by means of a volume assigned to a potentiometer on the control unit 6 (or by input/display of a more highly electronicized system, such as for example microprocessor/controller).
  • FIG. 7 diagrammatically shows a gas supply system with pressure-reducing device at the [0062] gas source 7. By varying the pressure of the supply gas, this may be a compressed-gas vessel with pressure-reducing device or a liquefied-gas vessel with evaporation device, with or without pressure-reducing device, the volumetric flow rate can be altered. This is detected by means of the pressure measurement and the new time or the new volume administered can be displayed and calculated/controlled.
  • FIG. 8 diagrammatically shows the profile of the total volumetric flow rate analogously to the nasal pressure P[0063] N (bottom diagram) when metering a plurality of gases with the respective volumetric flow rates V1, V2, Vn. A suitable gas supply system is shown in FIG. 11.
  • Analogously to FIG. 8, FIG. 9 shows the profile of volumetric flow rates produced for various gases. FIGS. 8 and 9 are examples of different mixing ratios produced for a plurality of gases. [0064]
  • FIG. 10 diagrammatically shows a gas supply system with a plurality of [0065] gas sources 7, 7′ and 7″ and assigned pressure sensors 1, 1′ and 1″.
  • FIG. 11 diagrammatically shows a gas metering system with a plurality of [0066] gas sources 7, 7′ and 7″ and associated pressure-reducing devices (e.g. nozzles) 5, 5′ and 5″ and a sensor 1 for controlling the solenoid valves by means of a control unit 6.
  • FIG. 12 shows the delivery of gas from the gas sources [0067] 7 (e.g. oxygen) and 7′ (e.g. NO source) via a sensor 1 and/or a gas analysis unit.
  • FIG. 13 shows a gas supply system with a plurality of [0068] gas sources 7 to 7′″ (e.g. oxygen, NO source, helium, carbon dioxide) using sensors 1 to 1′″ and patient-mounted sensor 1 IV and filter element 9.
  • FIG. 14 diagrammatically shows a gas supply system for liquid oxygen and NO-containing gas. The valves V[0069] 1 and V2 (e.g. solenoid valves) are controlled by means of the patient-mounted sensor 1 (e.g. pressure sensor) in conjunction with the control unit 6.
  • FIG. 15 diagrammatically shows the temporal profile of volumetric flow rates of oxygen and NO-containing gas and of the measured nasal pressure P[0070] N.
  • FIG. 16 shows a mixing device for gases, comprising hollow-[0071] cylindrical part 11 and mixing body 10, which is formed by a twisted flat body (e.g. made from metal, plastic or glass; ends of the flat body rotated with respect to one another, e.g. 180° or 360°). The mixing device, as mixing path, is preferably fitted in the respiratory tube of the gas supply system.
  • EXAMPLE NO Metering as a Function of Oxygen Volume
  • A portable unit for the combined metering of oxygen and NO (in nitrogen) contains a storage vessel for cold-liquefied oxygen with integrated evaporation system (capacity: 0.5 liters), a compressed-gas vessel for NO-nitrogen gas mixture (typically 800 to 1000 ppm NO in N[0072] 2; geometric cylinder volume: 0.2 to 1.0 liter; filling pressure: 150 to 200 bar), a control unit for controlling the metering of oxygen and NO gas mixture, at least 2 electrically controllable solenoid valves, gas hoses and nasal spectacles with pressure sensor, NO sensor and NO2 sensor in the respiratory gas line, a warning system and safety device (alarm: when NO gas mixture cylinder empty, when oxygen storage vessel empty, excessive oxygen, NO or NO2 concentration in the respiratory gas).
  • The pressure sensor is used to trigger the gas metering (inspiration-synchronized gas metering). At the start of inspiration, the solenoid valve for oxygen metering and the solenoid valve for NO gas mixture metering are opened. The volume of oxygen metered per inspiration is preset, e.g. V[0073] O2=50 ml. A set oxygen volumetric flow rate VO2′ of 3000 ml/minute results in a pulse width tO2 of 1 second. The NO concentration to be set in the respiratory gas volume Vges (Vges=VO2+VNO) is to amount to CNO=35 ppm. The NO gas mixture contains 1000 ppm NO. The preset NO gas mixture volumetric flow rate VNO′ amounts to 500 ml/minute. The metered volume of NO gas mixture VNO required to set the NO concentration CNO=35 ppm (volume/volume) in the respiratory gas is calculated as follows:
  • C NO=(V NO *F)/V ges=(V NO *F)/(V O2 +V NO)
  • where F: NO concentration in the NO gas mixture. [0074]
  • It follows that V[0075] NO=(VO2*CNO)/(F−CNO).
  • Where V[0076] O2=3000 ml, CNO=35 (ppm) and F=1000 (ppm), VNO=1.8 ml.
  • The opening time of the NO metering valve (in this function open/shut function) is fixed by V[0077] NO=VNO′*tNO. The opening time of the solenoid valve for NO gas mixture metering is therefore 218 milliseconds (where VNO′=500 ml/minute). For reasons of homogeneity, it is advantageous for the metering conditions to be selected in such a way that the NO metering time is tNO=½tO2. This is achieved by reducing the volumetric flow rate VNO′ by lowering the preliminary pressure in the gas metering line. The preliminary gas pressure is advantageously reduced by means of a controllable diaphragm or nozzle incorporated in the gas metering line (automatic adjustment of the diaphragm aperture or nozzle aperture).
  • In order to simplify illustration, the calculation example contains only one predetermined NO concentration. It is preferable for the NO concentration to be varied by means of a control program or a sensor control system. [0078]

Claims (16)

1. Gas supply system for treating humans or mammals by inhalation, having a controlled gas metering of at least one gas, characterized by a program control unit, a sensor control unit or a combined programme/sensor control unit for inspiration-synchronized gas metering which is carried out in a pulse-modulated manner or in sequences.
2. Gas supply system according to claim 1, characterized in that pulse width, pulse height and number of pulses within one breath are preset or variable.
3. Gas supply system according to claim 1 or 2, characterized in that the gas metering is carried out by means of a basic metering and an additional metering of the gas.
4. Gas supply system according to one of claims 1 to 3, characterized in that the gas metering is controlled by means of a response curve.
5. Gas supply system according to one of claims 1 to 4, characterized in that the gas supply system contains a pressure vessel containing compressed gas, a vessel containing cold-liquefied gas or a gas generator as the gas source.
6. Gas supply system according to one of claims 1 to 5, characterized in that oxygen and an NO-containing gas; an NO-containing gas and hydrogen; oxygen and hydrogen; oxygen and helium; oxygen, an NO-containing gas and hydrogen; oxygen, an NO-containing gas and helium; oxygen, carbon dioxide and helium; or oxygen, an NO-containing gas, carbon dioxide and hydrogen are metered in parallel.
7. Gas supply system according to one of claims 1 to 6, characterized in that the gas supply system contains a gas-specific sensor, a gas sensor, a gas analyser, a pressure sensor, a pressure sensor and a gas sensor, a sound sensor, a sound pressure sensor, a gas volumetric flow sensor, a gas volume sensor, a sensor for measuring the oxygen saturation in the peripheral blood, for blood gas analysis, for measuring the oxygen saturation in the peripheral blood, for measuring blood pressure, for measuring pulmonary blood pressure, for measuring heart rate or for measuring cardiac output.
8. Gas supply system according to one of claims 1 to 7, characterized in that the gas supply system contains one or more sensors for simultaneously measuring at least two variables, the variables being used to control the gas metering.
9. Gas supply system according to one of claims 1 to 8, characterized in that the gas supply system contains one or more sensors for simultaneously measuring heart rate and oxygen saturation in the peripheral blood or pulmonary vessel pressure and oxygen saturation in the peripheral blood.
10. Gas supply system according to one of claims 1 to 9, characterized in that the gas supply system contains a system for controlling the gas metering of at least one gas, which system is adaptive or related to the human or mammal being treated.
11. Gas supply system according to one of claims 1 to 10, characterized in that the gas supply system contains a sensor for a warning system or for controlling a safety shut-off for gas metering.
12. Gas supply system according to one of claims 1 to 11, characterized in that the gas supply system contains a program control unit and/or sensor control unit for the continuous or discontinuous temporal change in the gas volume or gas concentration of a gas in the respiratory gas.
13. Gas supply system according to one of claims 1 to 12, characterized in that the gas supply system, after one or more metered gases have been fed in, contains a mixing path and/or a mixing member in the respiratory gas line.
14. Method for metering gas for treating humans or mammals by inhalation with one or more gases, characterized in that the gas metering takes place in an inspiration-synchronized manner and by means of a program control unit, a sensor control unit or a combined program/sensor control unit, in a pulse-modulated manner or in sequences.
15. Method according to claim 14, characterized in that the sequence of the program for controlling the metering of a gas is dependent on a measured variable being reached, and program sequences of the gas metering are triggered in the event of a threshold of a measured variable being exceeded or undershot.
16. Method according to claim 14, characterized in that measured values from the previous breath are used to control the metering of a gas.
US09/341,975 1997-01-17 1998-01-15 Controlled gas-supply system Abandoned US20020185126A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/737,431 US7861717B1 (en) 1997-01-17 2003-12-16 Controlled gas-supply system

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19701617.0 1997-01-17
DE19701617A DE19701617A1 (en) 1997-01-17 1997-01-17 Respiration system with sequence-controlled, non-uniform gas metering or sensor-controlled gas-metering
DE19746742A DE19746742A1 (en) 1997-10-23 1997-10-23 Inhalation gas supply
DE19746742.3 1997-10-23
US10/737,431 US7861717B1 (en) 1997-01-17 2003-12-16 Controlled gas-supply system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/737,431 Continuation-In-Part US7861717B1 (en) 1997-01-17 2003-12-16 Controlled gas-supply system

Publications (1)

Publication Number Publication Date
US20020185126A1 true US20020185126A1 (en) 2002-12-12

Family

ID=43466707

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/341,975 Abandoned US20020185126A1 (en) 1997-01-17 1998-01-15 Controlled gas-supply system
US10/737,431 Expired - Fee Related US7861717B1 (en) 1997-01-17 2003-12-16 Controlled gas-supply system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/737,431 Expired - Fee Related US7861717B1 (en) 1997-01-17 2003-12-16 Controlled gas-supply system

Country Status (11)

Country Link
US (2) US20020185126A1 (en)
EP (1) EP0973443B1 (en)
JP (1) JP2001517108A (en)
AT (1) ATE320829T1 (en)
AU (1) AU5863898A (en)
CA (1) CA2278053C (en)
DE (1) DE59813457D1 (en)
DK (1) DK0973443T3 (en)
ES (1) ES2262220T3 (en)
PT (1) PT973443E (en)
WO (1) WO1998031282A1 (en)

Cited By (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040159323A1 (en) * 1997-07-25 2004-08-19 Minnesota Innovative Technologies And Instruments Control of respiratory oxygen delivery
EP1477201A1 (en) * 2003-05-13 2004-11-17 INO Therapeutics GmbH Process and device for a controlled admixing of a gas or a gas mixture to a stream of a gas or a mixture of gases
US20050228304A1 (en) * 2004-04-01 2005-10-13 Elliott Stephen B Method and system of respiratory therapy employing heart rate variability coherence
EP1755715A2 (en) * 2004-05-11 2007-02-28 SensorMedics Corporation Intermittent dosing of nitric oxide gas
EP1772098A1 (en) 2005-10-10 2007-04-11 Viasys Healthcare GmbH Measuring head for diagnostic instruments and method
US20070181208A1 (en) * 2006-02-06 2007-08-09 Honeywell International Inc. System and method for preventing blow-by of liquefied gases
US20070190184A1 (en) * 2006-02-16 2007-08-16 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
EP1981575A1 (en) * 2006-01-24 2008-10-22 Devx Tech IP Limited A fluid mixing apparatus with an improved mixer
FR2923720A1 (en) * 2007-11-16 2009-05-22 Taema Sa APPARATUS FOR XENON OR N2O RESPIRATORY ANESTHESIA.
US20090241947A1 (en) * 2006-07-20 2009-10-01 Cnr- Consiglio Nazionale Delle Richerche Apparatus for controlled and automatic medical gas dispensing
US20110067697A1 (en) * 2009-07-15 2011-03-24 Lellouche Francois Method and Device for Administering Oxygen to a Patient and Monitoring the Patient
US20110277758A1 (en) * 2010-05-11 2011-11-17 Carefusion 207, Inc. Patient circuit integrity alarm using exhaled co2
US8267085B2 (en) 2009-03-20 2012-09-18 Nellcor Puritan Bennett Llc Leak-compensated proportional assist ventilation
US8272379B2 (en) 2008-03-31 2012-09-25 Nellcor Puritan Bennett, Llc Leak-compensated flow triggering and cycling in medical ventilators
EP2563443A1 (en) * 2010-04-29 2013-03-06 Maquet Vertrieb und Service Deutschland Gmbh Method and device for supplying at least one medical gas to a patient receiving artificial respiration with the aid of a respirator
US8418691B2 (en) 2009-03-20 2013-04-16 Covidien Lp Leak-compensated pressure regulated volume control ventilation
US8424521B2 (en) 2009-02-27 2013-04-23 Covidien Lp Leak-compensated respiratory mechanics estimation in medical ventilators
US8431163B2 (en) 2009-06-30 2013-04-30 Ino Therapeutics Llc Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
US8457706B2 (en) 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
US8485184B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for monitoring and displaying respiratory information
US8551006B2 (en) 2008-09-17 2013-10-08 Covidien Lp Method for determining hemodynamic effects
US8554298B2 (en) 2010-09-21 2013-10-08 Cividien LP Medical ventilator with integrated oximeter data
CN103379935A (en) * 2011-02-21 2013-10-30 皇家飞利浦有限公司 Method and arrangement for generating a gas stream comprising nitric oxide
EP2696927A1 (en) * 2011-04-13 2014-02-19 Michael Klein Gas delivery method and apparatus
US8676285B2 (en) 2010-07-28 2014-03-18 Covidien Lp Methods for validating patient identity
US20140109910A1 (en) * 2011-07-01 2014-04-24 Koninklijke Philips N.V. System and method for limited flow respiratory therapy
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US8746248B2 (en) 2008-03-31 2014-06-10 Covidien Lp Determination of patient circuit disconnect in leak-compensated ventilatory support
US8770199B2 (en) 2012-12-04 2014-07-08 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8789529B2 (en) 2009-08-20 2014-07-29 Covidien Lp Method for ventilation
US20140261415A1 (en) * 2013-03-18 2014-09-18 Ino Therapeutics Llc Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
WO2015037002A3 (en) * 2013-09-11 2015-04-30 Advanced Inhalation Therapies (Ait) Ltd. System for nitric oxide inhalation
US9089657B2 (en) 2011-10-31 2015-07-28 Covidien Lp Methods and systems for gating user initiated increases in oxygen concentration during ventilation
WO2016005710A1 (en) * 2014-07-10 2016-01-14 Nixys Improved method for dispensing a gaseous mixture of medical oxygen o2 and another medical gas
FR3023487A1 (en) * 2014-07-10 2016-01-15 Nixys IMPROVED DEVICE FOR DISPENSING A GAS MIXTURE OF OXYGEN O2 AND ANOTHER MEDICAL GAS
EP3108920A1 (en) * 2015-06-22 2016-12-28 Linde AG Device for delivering nitric oxide and oxygen to a patient
US20170106161A1 (en) * 2015-10-19 2017-04-20 Hsin-Yung Lin Breathing mask and gas providing device
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US9675771B2 (en) 2013-10-18 2017-06-13 Covidien Lp Methods and systems for leak estimation
WO2017100729A1 (en) * 2015-12-11 2017-06-15 Geno Llc Method and apparatus for administering gases including nitric oxide
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US20170347960A1 (en) * 2016-06-06 2017-12-07 General Electric Company Mobile newborn care bed and methods of newborn care
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US9993604B2 (en) 2012-04-27 2018-06-12 Covidien Lp Methods and systems for an optimized proportional assist ventilation
US20180177969A1 (en) * 2015-06-23 2018-06-28 Nihon Kohden Corporation Treatment gas supplying apparatus
WO2018135350A1 (en) * 2017-01-17 2018-07-26 Nihon Kohden Corporation Mixed gas supplying apparatus
US10207069B2 (en) 2008-03-31 2019-02-19 Covidien Lp System and method for determining ventilator leakage during stable periods within a breath
US10286176B2 (en) 2017-02-27 2019-05-14 Third Pole, Inc. Systems and methods for generating nitric oxide
US10328228B2 (en) 2017-02-27 2019-06-25 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US10328231B2 (en) 2013-03-15 2019-06-25 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US10435798B2 (en) 2015-08-11 2019-10-08 Miz Company Limited Hydrogen gas generator
US20200359966A1 (en) * 2019-05-17 2020-11-19 Gyrus Acmi, Inc. Collateral ventilation assessment system
US11045620B2 (en) 2019-05-15 2021-06-29 Third Pole, Inc. Electrodes for nitric oxide generation
US11052216B2 (en) * 2013-06-19 2021-07-06 Hsin-Yung Lin Anti-explosion gas generator for health use
US11324954B2 (en) 2019-06-28 2022-05-10 Covidien Lp Achieving smooth breathing by modified bilateral phrenic nerve pacing
US11479464B2 (en) 2019-05-15 2022-10-25 Third Pole, Inc. Systems and methods for generating nitric oxide
US11478594B2 (en) 2018-05-14 2022-10-25 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
WO2022241416A1 (en) * 2021-05-13 2022-11-17 Penland Foundation Treatment of ards and other conditions caused by acutely elevated cytokine levels and post ards chronic cytokine production using inhaled anesthetics
US11691879B2 (en) 2020-01-11 2023-07-04 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection
US11827989B2 (en) 2020-06-18 2023-11-28 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
US11833309B2 (en) 2017-02-27 2023-12-05 Third Pole, Inc. Systems and methods for generating nitric oxide

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8592898A (en) * 1997-07-25 1999-02-16 Minnesota Innovative Technologies & Instruments Corporation (Miti) Control device for supplying supplemental respiratory oxygen
JPH11276459A (en) * 1998-03-31 1999-10-12 Fukuda Sangyo:Kk Lung function testing device
US6089229A (en) * 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US6467479B1 (en) 1998-10-09 2002-10-22 The Brigham And Women's Hospital, Inc. Method and apparatus for delivering a measured of a gas
DE19851380A1 (en) * 1998-11-07 2000-05-11 Messer Griesheim Gmbh Perfuming oxygen
FI982652A (en) 1998-12-08 2000-06-09 Instrumentarium Oyj Arrangement in connection with the equipment used in patient care
FI110065B (en) 1998-12-08 2002-11-29 Instrumentarium Oyj Device in a feedback control system
JP4588135B2 (en) * 1999-04-22 2010-11-24 イー. フィリップス ロバート Supply system responsive to activity
DE19960404A1 (en) * 1999-12-15 2001-07-05 Messer Austria Gmbh Gumpoldski Expiration-dependent gas metering
DE19961206A1 (en) 1999-12-18 2001-07-05 Messer Austria Gmbh Gumpoldski Tidal volume-dependent gas dosing
DE10025202A1 (en) 2000-05-20 2001-11-29 Messer Austria Gmbh Gumpoldski Gas dosing device with catheter
US6651658B1 (en) * 2000-08-03 2003-11-25 Sequal Technologies, Inc. Portable oxygen concentration system and method of using the same
SE517723C2 (en) * 2000-11-07 2002-07-09 Aneo Ab Arrangement for pulmonary ventilatory therapy
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6675798B1 (en) * 2001-01-18 2004-01-13 Automed - Automatic Dosage Systems, Ltd. Automatically regulating oxygen flow to a patient
WO2002087673A1 (en) * 2001-04-25 2002-11-07 Messer Austria Gmbh Aerosol dosing device
US7004168B2 (en) * 2001-09-07 2006-02-28 Respironics, Inc. Face mask for gas monitoring during supplemental oxygen delivery
SE0103309D0 (en) * 2001-10-04 2001-10-04 Siemens Elema Ab Dosing System
GB2388550A (en) * 2002-05-16 2003-11-19 Boc Group Plc Apparatus for breathable gas delivery
US20040059205A1 (en) * 2002-09-20 2004-03-25 Sven-Erik Carlson Configuration for monitoring the state of health of a person
DE102004063698B4 (en) * 2004-12-28 2010-02-04 Dae Systems Gmbh Emergency oxygen system for aircraft passengers
DE102005000922A1 (en) * 2005-01-07 2006-07-20 Seleon Gmbh Aerial goggles, nosepiece, Y-piece and procedures
WO2006090260A1 (en) * 2005-02-28 2006-08-31 Pulmonox Technologies Corporation Means and method for supplying therapeutic gas to a spontaneously breathing patient
CN101203263B (en) * 2005-06-23 2012-10-24 瑞思迈巴黎公司 Respiratory assistance apparatus having independent assistance unit
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
EP1930043B8 (en) * 2006-12-05 2018-06-27 Löwenstein Medical Technology S.A. Method for determining oxygen concentration in a breathing gas mixture
US9586018B2 (en) 2007-01-26 2017-03-07 Cs Medical, Inc. System for providing flow-targeted ventilation synchronized to a patients breathing cycle
US8020558B2 (en) 2007-01-26 2011-09-20 Cs Medical, Inc. System for providing flow-targeted ventilation synchronized to a patient's breathing cycle
US20080210236A1 (en) * 2007-03-01 2008-09-04 Resmed Limited Tubing management system
DE112009001180A5 (en) * 2008-03-17 2011-02-17 Technologie Institut Medizin (Tim) Gmbh Control device for the application of volatile anesthetic gases
US9119977B2 (en) * 2008-07-11 2015-09-01 Zodiac Aerotechnics Oxygen breathing device with mass flow control
US10960168B2 (en) * 2008-08-21 2021-03-30 Vero Biotech LLC Delivery of high concentration nitric oxide
US8393323B2 (en) 2008-09-30 2013-03-12 Covidien Lp Supplemental gas safety system for a breathing assistance system
DE102009013396B3 (en) 2009-03-16 2010-08-05 Dräger Medical AG & Co. KG Apparatus and method for controlling the oxygen dosage of a ventilator
JP5692561B2 (en) * 2009-03-23 2015-04-01 エア・ウォーター株式会社 Medicinal gas administration device
US20110209702A1 (en) * 2010-02-26 2011-09-01 Nellcor Puritan Bennett Llc Proportional Solenoid Valve For Low Molecular Weight Gas Mixtures
JP2012228415A (en) * 2011-04-27 2012-11-22 Air Water Inc Oxygen concentrator
CA2854776C (en) * 2011-11-07 2020-08-18 Ino Therapeutics Llc Apparatus and method for monitoring nitric oxide delivery
JP6104513B2 (en) * 2012-03-09 2017-03-29 エア・ウォーター株式会社 Ventilator
US20130239962A1 (en) * 2012-03-15 2013-09-19 Ino Therapeutics Llc Methods Of Administering High Concentrations Of Nitric Oxide
JP6245613B2 (en) 2012-03-15 2017-12-13 マリンクロット ホスピタル プロダクツ アイピー リミテッド Administration of high concentrations of nitric oxide
IN2014MN02064A (en) * 2012-03-19 2015-08-21 Michael Klein
US20130273180A1 (en) * 2012-04-16 2013-10-17 Denise Barbut System and method for improving outcome of cerebral ischemia
WO2014024984A1 (en) * 2012-08-09 2014-02-13 大陽日酸株式会社 Hydrogen mixed gas supply device for medical purposes
JP6325564B2 (en) * 2012-11-05 2018-05-16 ゲノ エルエルシー Dual platform system for nitric oxide delivery
CA2905439A1 (en) * 2013-03-13 2014-10-02 Ino Therapeutics Llc Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide
ES2733343T3 (en) * 2013-03-15 2019-11-28 Massachusetts Gen Hospital Synthesis of nitric oxide gas for inhalation
ES2886513T3 (en) * 2013-03-15 2021-12-20 Massachusetts Gen Hospital Inspiratory Nitric Oxide Synthesis
FR3015000B1 (en) * 2013-12-12 2016-05-27 Air Liquide Sante (International) SYSTEM FOR STORING AND DISPENSING NO / NITROGEN MIXTURES
EP2937089A1 (en) 2014-04-23 2015-10-28 Linde AG Device for the treatment of, treatment of complications arising from, and/or prevention of respiratory disorders
MX2017004796A (en) 2014-10-20 2017-07-27 Massachusetts Gen Hospital Systems and methods for the synthesis of nitric oxide.
EP3020438A1 (en) * 2014-11-13 2016-05-18 Linde AG Device for ventilating a patient and method for operating a device for ventilating a patient
US20180126110A1 (en) * 2015-02-18 2018-05-10 Fisher & Paykel Healthcare Limited Flow therapy system
EP3259000B1 (en) * 2015-03-31 2022-11-09 Fisher & Paykel Healthcare Limited Apparatus for high gas flow
AU2016267090A1 (en) * 2015-05-25 2017-12-07 VERO Biotech LLC. Nitric oxide treatment system and method
JP2019515709A (en) 2016-03-25 2019-06-13 ザ ジェネラル ホスピタル コーポレイション Delivery system and method for electrical plasma synthesis of nitrides
DE102016006362A1 (en) 2016-05-30 2017-11-30 Technologie Institut Medizin GmbH (TIM) Inspiratory flow - synchronous gas admixture with respiratory gases
AU2018243493B2 (en) 2017-03-31 2020-10-15 The General Hospital Corporation Systems and methods for a cooled nitric oxide generator

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262686A (en) * 1978-07-20 1981-04-21 Dragerwerk Aktiengesellschaft Apparatus for the electrically controlled proportioning and mixing of gases
US4932402A (en) * 1986-04-11 1990-06-12 Puritan-Bennett Corporation Inspiration oxygen saver
US5370112A (en) * 1993-07-01 1994-12-06 Devilbiss Health Care, Inc. Method and means for powering portable oxygen supply systems
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5411059A (en) * 1994-02-01 1995-05-02 Essex Industries, Inc. Multiple flow rate fluid control valve assembly
US5423313A (en) * 1981-03-10 1995-06-13 Siemens-Elema Ab Respirator intended for connection to human or animal airways
US5735268A (en) * 1995-06-07 1998-04-07 Salter Labs Intermitten gas-insufflation apparatus and method therefor
US5738090A (en) * 1995-06-02 1998-04-14 Burkhard Lachmann Respiratory system for determining an opening pressure of a long system and maintaining the lung system open
US5752509A (en) * 1995-07-10 1998-05-19 Burkhard Lachmann Artificial ventilation system
US5890490A (en) * 1996-11-29 1999-04-06 Aylsworth; Alonzo C. Therapeutic gas flow monitoring system
US6269811B1 (en) * 1998-11-13 2001-08-07 Respironics, Inc. Pressure support system with a primary and a secondary gas flow and a method of using same

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583273A (en) * 1977-05-06 1981-01-21 Medishield Corp Ltd Lung ventilators
SE448347B (en) 1981-05-14 1987-02-16 Siemens Elema Ab SET FOR GAS MIXING IN PREDICTED PROPORTIONS
DE3416291A1 (en) * 1983-08-30 1985-03-14 Veb Kombinat Medizin- Und Labortechnik Leipzig, Ddr 7035 Leipzig Circuit arrangement for digital gas mixing and gas metering
FR2573311B1 (en) * 1984-11-20 1988-06-24 Boc Sa Ohmeda ARTIFICIAL VENTILATION APPARATUS HAVING A VOLUMETRIC INSPIRATORY ASSISTANCE DEVICE
GB2170731B (en) * 1985-02-09 1988-02-24 Paul Phillip Hope Time-controlled fluid mixers
US4686975A (en) 1985-05-03 1987-08-18 Applied Membrane Technology, Inc. Electronic respirable gas delivery device
US4832014A (en) 1985-10-02 1989-05-23 Perkins Warren E Method and means for dispensing two respirating gases by effecting a known displacement
JPS6294175A (en) * 1985-10-18 1987-04-30 鳥取大学長 Respiration synchronous type gas blowing apparatus and method
DE3702136A1 (en) 1987-01-24 1988-08-04 Draegerwerk Ag DEVICE FOR CONTROLLING AN EVAPORATOR BY MEANS OF PRESSURE VARIATIONS
DE3708146A1 (en) * 1987-03-13 1988-09-22 Medicommerz Gmbh Respiratory gas apparatus
DE3712598A1 (en) * 1987-04-14 1988-10-27 Siemens Ag INHALATION ANESTHESIS DEVICE
US4932401A (en) * 1988-04-01 1990-06-12 Perkins Warren E Two-gas variable ratio, variable dose, metering system and method of use
DE3817985A1 (en) * 1988-05-27 1989-12-07 Salvia Werk Gmbh DEVICE FOR SUPPORTING THE SPONTANEOUS BREATHING OF A PATIENT
DE3827383A1 (en) * 1988-08-12 1990-02-15 Oxytechnik Ges Systemtech ARC WELDING DEVICE
GB8824865D0 (en) 1988-10-24 1988-11-30 Antec Systems Gas sampling device & water trap
US5094235A (en) 1989-05-10 1992-03-10 Dragerwerk Aktiengesellschaft Anesthesia ventilating apparatus having a breathing circuit and control loops for anesthetic gas components
GB2235136A (en) * 1989-08-18 1991-02-27 Sabre Safety Ltd Positive pressure breathing apparatus
US4971049A (en) * 1989-11-06 1990-11-20 Pulsair, Inc. Pressure sensor control device for supplying oxygen
SE466188B (en) * 1990-02-16 1992-01-13 Hoek Instr Ab ACOUSTIC RESPIRATORY DETECTOR
WO1991014476A1 (en) 1990-03-22 1991-10-03 Methodist Hospital Of Indiana, Inc. Exhaled gas cooling device
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
DK0560928T3 (en) 1990-12-05 1997-12-01 Gen Hospital Corp Devices for the treatment of pulmonary vasoconstriction and asthma
US5320093A (en) 1990-12-21 1994-06-14 Brigham And Women's Hospital Rapid anesthesia emergence system using closed-loop PCO2 control
DE4309923C2 (en) * 1993-03-26 1995-02-16 Boesch Wilhelm Device for supplying breathing gas to a patient
DE4325319C1 (en) * 1993-07-29 1994-04-28 Messer Griesheim Gmbh Controlled nitric oxide dosing equipment - for respiration appts. used in adult respiratory distress syndrome treatment
DE4327730C1 (en) * 1993-08-18 1995-03-02 Messer Griesheim Gmbh Device for the administration of NO to spontaneously breathing patients with pulmonary disorders
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5558083A (en) * 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
DE69621320T2 (en) 1995-02-08 2002-11-21 Puritan Bennett Corp GAS MIXING DEVICE FOR A VENTILATOR
SE9504310D0 (en) 1995-12-01 1995-12-01 Siemens Elema Ab dosing device
SE9504311D0 (en) * 1995-12-01 1995-12-01 Siemens Elema Ab Breathing apparatus
SE9601719D0 (en) 1996-05-06 1996-05-06 Siemens Elema Ab Dosage for supply of additive gas or liquid to respiratory gas in anesthesia or ventilator
US5918596A (en) * 1997-04-22 1999-07-06 Instrumentarium Corp. Special gas dose delivery apparatus for respiration equipment
US6125846A (en) * 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
SE9704661D0 (en) * 1997-12-15 1997-12-15 Siemens Elema Ab Fresh gas system and method of gasification of liquid anesthetic
US6581599B1 (en) * 1999-11-24 2003-06-24 Sensormedics Corporation Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262686A (en) * 1978-07-20 1981-04-21 Dragerwerk Aktiengesellschaft Apparatus for the electrically controlled proportioning and mixing of gases
US5423313A (en) * 1981-03-10 1995-06-13 Siemens-Elema Ab Respirator intended for connection to human or animal airways
US4932402A (en) * 1986-04-11 1990-06-12 Puritan-Bennett Corporation Inspiration oxygen saver
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5370112A (en) * 1993-07-01 1994-12-06 Devilbiss Health Care, Inc. Method and means for powering portable oxygen supply systems
US5411059A (en) * 1994-02-01 1995-05-02 Essex Industries, Inc. Multiple flow rate fluid control valve assembly
US5738090A (en) * 1995-06-02 1998-04-14 Burkhard Lachmann Respiratory system for determining an opening pressure of a long system and maintaining the lung system open
US5735268A (en) * 1995-06-07 1998-04-07 Salter Labs Intermitten gas-insufflation apparatus and method therefor
US5752509A (en) * 1995-07-10 1998-05-19 Burkhard Lachmann Artificial ventilation system
US5890490A (en) * 1996-11-29 1999-04-06 Aylsworth; Alonzo C. Therapeutic gas flow monitoring system
US6269811B1 (en) * 1998-11-13 2001-08-07 Respironics, Inc. Pressure support system with a primary and a secondary gas flow and a method of using same

Cited By (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040159323A1 (en) * 1997-07-25 2004-08-19 Minnesota Innovative Technologies And Instruments Control of respiratory oxygen delivery
US7331343B2 (en) 1997-07-25 2008-02-19 Minnesota Innovative Technologies & Instruments Corporation (Miti) Control of supplemental respiratory oxygen
EP1477201A1 (en) * 2003-05-13 2004-11-17 INO Therapeutics GmbH Process and device for a controlled admixing of a gas or a gas mixture to a stream of a gas or a mixture of gases
US20050228304A1 (en) * 2004-04-01 2005-10-13 Elliott Stephen B Method and system of respiratory therapy employing heart rate variability coherence
US9095534B2 (en) * 2004-05-11 2015-08-04 Sensormedics Corporation Intermittent dosing of nitric oxide gas
US20070144515A1 (en) * 2004-05-11 2007-06-28 Alex Stenzler Intermittent dosing of nitric oxide gas
EP1755715A2 (en) * 2004-05-11 2007-02-28 SensorMedics Corporation Intermittent dosing of nitric oxide gas
EP1755715A4 (en) * 2004-05-11 2010-03-24 Sensormedics Corp Intermittent dosing of nitric oxide gas
US20120199123A1 (en) * 2004-05-11 2012-08-09 Pulmonox Technologies Corporation Intermittent dosing of nitric oxide gas
US7955294B2 (en) * 2004-05-11 2011-06-07 Sensormedics Corporation Intermittent dosing of nitric oxide gas
US20070084466A1 (en) * 2005-10-10 2007-04-19 Jurgen Reinstadtler Measuring head for diagnostic instruments and method
EP1772098A1 (en) 2005-10-10 2007-04-11 Viasys Healthcare GmbH Measuring head for diagnostic instruments and method
US9320456B2 (en) 2005-10-10 2016-04-26 Carefusion Germany 234 Gmbh Measuring head for diagnostic instruments and method
EP1981575A4 (en) * 2006-01-24 2014-07-30 Devx Tech Ip Ltd A fluid mixing apparatus with an improved mixer
EP1981575A1 (en) * 2006-01-24 2008-10-22 Devx Tech IP Limited A fluid mixing apparatus with an improved mixer
US20070181208A1 (en) * 2006-02-06 2007-08-09 Honeywell International Inc. System and method for preventing blow-by of liquefied gases
US20070190184A1 (en) * 2006-02-16 2007-08-16 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US10537697B2 (en) * 2006-02-16 2020-01-21 Mallinckrodt Hospital Products IP Limited Method and apparatus for generating nitric oxide for medical use
WO2008076136A1 (en) * 2006-02-16 2008-06-26 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US9278111B2 (en) 2006-02-16 2016-03-08 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
AU2007334600B2 (en) * 2006-02-16 2010-04-08 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US20160136376A1 (en) * 2006-02-16 2016-05-19 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US20090241947A1 (en) * 2006-07-20 2009-10-01 Cnr- Consiglio Nazionale Delle Richerche Apparatus for controlled and automatic medical gas dispensing
WO2009068790A2 (en) * 2007-11-16 2009-06-04 Air Liquide Medical Systems Respiratory anaesthesia apparatus using xenon or n2o
WO2009068790A3 (en) * 2007-11-16 2009-09-03 Air Liquide Medical Systems Respiratory anaesthesia apparatus using xenon or n<sb>2</sb>o
FR2923720A1 (en) * 2007-11-16 2009-05-22 Taema Sa APPARATUS FOR XENON OR N2O RESPIRATORY ANESTHESIA.
US9421338B2 (en) 2008-03-31 2016-08-23 Covidien Lp Ventilator leak compensation
US8272380B2 (en) 2008-03-31 2012-09-25 Nellcor Puritan Bennett, Llc Leak-compensated pressure triggering in medical ventilators
US8434480B2 (en) 2008-03-31 2013-05-07 Covidien Lp Ventilator leak compensation
US8272379B2 (en) 2008-03-31 2012-09-25 Nellcor Puritan Bennett, Llc Leak-compensated flow triggering and cycling in medical ventilators
US10207069B2 (en) 2008-03-31 2019-02-19 Covidien Lp System and method for determining ventilator leakage during stable periods within a breath
US11027080B2 (en) 2008-03-31 2021-06-08 Covidien Lp System and method for determining ventilator leakage during stable periods within a breath
US8746248B2 (en) 2008-03-31 2014-06-10 Covidien Lp Determination of patient circuit disconnect in leak-compensated ventilatory support
US8457706B2 (en) 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
US8485185B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for ventilation in proportion to patient effort
US10828437B2 (en) 2008-06-06 2020-11-10 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US9956363B2 (en) 2008-06-06 2018-05-01 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US9126001B2 (en) 2008-06-06 2015-09-08 Covidien Lp Systems and methods for ventilation in proportion to patient effort
US9114220B2 (en) 2008-06-06 2015-08-25 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US8826907B2 (en) 2008-06-06 2014-09-09 Covidien Lp Systems and methods for determining patient effort and/or respiratory parameters in a ventilation system
US8485184B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for monitoring and displaying respiratory information
US8485183B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US9925345B2 (en) 2008-06-06 2018-03-27 Covidien Lp Systems and methods for determining patient effort and/or respiratory parameters in a ventilation system
US9414769B2 (en) 2008-09-17 2016-08-16 Covidien Lp Method for determining hemodynamic effects
US8551006B2 (en) 2008-09-17 2013-10-08 Covidien Lp Method for determining hemodynamic effects
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US8424521B2 (en) 2009-02-27 2013-04-23 Covidien Lp Leak-compensated respiratory mechanics estimation in medical ventilators
US8418691B2 (en) 2009-03-20 2013-04-16 Covidien Lp Leak-compensated pressure regulated volume control ventilation
US8267085B2 (en) 2009-03-20 2012-09-18 Nellcor Puritan Bennett Llc Leak-compensated proportional assist ventilation
US8448641B2 (en) 2009-03-20 2013-05-28 Covidien Lp Leak-compensated proportional assist ventilation
US8978650B2 (en) 2009-03-20 2015-03-17 Covidien Lp Leak-compensated proportional assist ventilation
US8973577B2 (en) 2009-03-20 2015-03-10 Covidien Lp Leak-compensated pressure regulated volume control ventilation
US8795741B2 (en) 2009-06-30 2014-08-05 Ino Therapeutics Llc Methods for treating patients who are candidates for inhaled nitric oxide treatment
US8846112B2 (en) 2009-06-30 2014-09-30 Ino Therapeutics Llc Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
US8431163B2 (en) 2009-06-30 2013-04-30 Ino Therapeutics Llc Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
US11931377B2 (en) 2009-06-30 2024-03-19 Mallinckrodt Hospital Products IP Limited Methods of administering inhaled nitric oxide gas
US20110067697A1 (en) * 2009-07-15 2011-03-24 Lellouche Francois Method and Device for Administering Oxygen to a Patient and Monitoring the Patient
US9364623B2 (en) 2009-07-15 2016-06-14 UNIVERSITé LAVAL Method and device for administering oxygen to a patient and monitoring the patient
US8789529B2 (en) 2009-08-20 2014-07-29 Covidien Lp Method for ventilation
EP2563443A1 (en) * 2010-04-29 2013-03-06 Maquet Vertrieb und Service Deutschland Gmbh Method and device for supplying at least one medical gas to a patient receiving artificial respiration with the aid of a respirator
US8905019B2 (en) * 2010-05-11 2014-12-09 Carefusion 207, Inc. Patient circuit integrity alarm using exhaled CO2
US20110277758A1 (en) * 2010-05-11 2011-11-17 Carefusion 207, Inc. Patient circuit integrity alarm using exhaled co2
US8676285B2 (en) 2010-07-28 2014-03-18 Covidien Lp Methods for validating patient identity
US8554298B2 (en) 2010-09-21 2013-10-08 Cividien LP Medical ventilator with integrated oximeter data
CN103379935A (en) * 2011-02-21 2013-10-30 皇家飞利浦有限公司 Method and arrangement for generating a gas stream comprising nitric oxide
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US10576238B2 (en) 2011-04-13 2020-03-03 Thornhill Scientific Inc. Gas delivery method and apparatus
EP2696927A4 (en) * 2011-04-13 2015-01-07 Michael Klein Gas delivery method and apparatus
US9555209B2 (en) * 2011-04-13 2017-01-31 Michael Klein Gas delivery method and apparatus
US11464934B2 (en) 2011-04-13 2022-10-11 Thornhill Scientific Inc. Gas delivery method and apparatus
US20140053837A1 (en) * 2011-04-13 2014-02-27 Michael Klein Gas delivery method and apparatus
EP2696927A1 (en) * 2011-04-13 2014-02-19 Michael Klein Gas delivery method and apparatus
US9987444B2 (en) * 2011-07-01 2018-06-05 Koninklijke Philips N.V. System and method for limited flow respiratory therapy
US20140109910A1 (en) * 2011-07-01 2014-04-24 Koninklijke Philips N.V. System and method for limited flow respiratory therapy
US9089657B2 (en) 2011-10-31 2015-07-28 Covidien Lp Methods and systems for gating user initiated increases in oxygen concentration during ventilation
US10806879B2 (en) 2012-04-27 2020-10-20 Covidien Lp Methods and systems for an optimized proportional assist ventilation
US9993604B2 (en) 2012-04-27 2018-06-12 Covidien Lp Methods and systems for an optimized proportional assist ventilation
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US11642042B2 (en) 2012-07-09 2023-05-09 Covidien Lp Systems and methods for missed breath detection and indication
US9550039B2 (en) 2012-12-04 2017-01-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US10918819B2 (en) 2012-12-04 2021-02-16 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US10130783B2 (en) 2012-12-04 2018-11-20 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US8770199B2 (en) 2012-12-04 2014-07-08 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
US9032959B2 (en) 2012-12-04 2015-05-19 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
US10556082B2 (en) 2012-12-04 2020-02-11 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
US10328231B2 (en) 2013-03-15 2019-06-25 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
US20140261415A1 (en) * 2013-03-18 2014-09-18 Ino Therapeutics Llc Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
US10342948B2 (en) * 2013-03-18 2019-07-09 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
US20210290886A1 (en) * 2013-06-19 2021-09-23 Hsin-Yung Lin Anti-explosion gas generator for health use
US11865265B2 (en) * 2013-06-19 2024-01-09 Hsin-Yung Lin Anti-explosion gas generator for health use
US11052216B2 (en) * 2013-06-19 2021-07-06 Hsin-Yung Lin Anti-explosion gas generator for health use
US20160228670A1 (en) * 2013-09-11 2016-08-11 Advanced Inhalation Therapies (Ait) Ltd. System for nitric oxide inhalation
WO2015037002A3 (en) * 2013-09-11 2015-04-30 Advanced Inhalation Therapies (Ait) Ltd. System for nitric oxide inhalation
US10207068B2 (en) 2013-10-18 2019-02-19 Covidien Lp Methods and systems for leak estimation
US11235114B2 (en) 2013-10-18 2022-02-01 Covidien Lp Methods and systems for leak estimation
US9675771B2 (en) 2013-10-18 2017-06-13 Covidien Lp Methods and systems for leak estimation
WO2016005710A1 (en) * 2014-07-10 2016-01-14 Nixys Improved method for dispensing a gaseous mixture of medical oxygen o2 and another medical gas
FR3023487A1 (en) * 2014-07-10 2016-01-15 Nixys IMPROVED DEVICE FOR DISPENSING A GAS MIXTURE OF OXYGEN O2 AND ANOTHER MEDICAL GAS
FR3023488A1 (en) * 2014-07-10 2016-01-15 Nixys METHOD FOR IMPROVED DISTRIBUTION OF A GAS MIXTURE OF MEDICAL OXYGEN O2 AND ANOTHER MEDICAL GAS
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US10864336B2 (en) 2014-08-15 2020-12-15 Covidien Lp Methods and systems for breath delivery synchronization
US10940281B2 (en) 2014-10-27 2021-03-09 Covidien Lp Ventilation triggering
US11712174B2 (en) 2014-10-27 2023-08-01 Covidien Lp Ventilation triggering
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
EP3108920A1 (en) * 2015-06-22 2016-12-28 Linde AG Device for delivering nitric oxide and oxygen to a patient
US20180304038A1 (en) * 2015-06-22 2018-10-25 Linde Aktiengesellschaft Device for delivering nitric oxide and oxygen to a patient
WO2016207227A1 (en) * 2015-06-22 2016-12-29 Linde Ag Device for delivering nitric oxide and oxygen to a patient
US20180177969A1 (en) * 2015-06-23 2018-06-28 Nihon Kohden Corporation Treatment gas supplying apparatus
US10435798B2 (en) 2015-08-11 2019-10-08 Miz Company Limited Hydrogen gas generator
US20170106161A1 (en) * 2015-10-19 2017-04-20 Hsin-Yung Lin Breathing mask and gas providing device
WO2017100729A1 (en) * 2015-12-11 2017-06-15 Geno Llc Method and apparatus for administering gases including nitric oxide
US20170347960A1 (en) * 2016-06-06 2017-12-07 General Electric Company Mobile newborn care bed and methods of newborn care
CN109310219A (en) * 2016-06-06 2019-02-05 通用电气公司 Mobile neonatal care bed and neonatal care method
WO2018135350A1 (en) * 2017-01-17 2018-07-26 Nihon Kohden Corporation Mixed gas supplying apparatus
US10576239B2 (en) 2017-02-27 2020-03-03 Third Pole, Inc. System and methods for ambulatory generation of nitric oxide
US10695523B2 (en) 2017-02-27 2020-06-30 Third Pole, Inc. Systems and methods for generating nitric oxide
US11033705B2 (en) 2017-02-27 2021-06-15 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US10946163B2 (en) 2017-02-27 2021-03-16 Third Pole, Inc. Systems and methods for generating nitric oxide
US10286176B2 (en) 2017-02-27 2019-05-14 Third Pole, Inc. Systems and methods for generating nitric oxide
US11376390B2 (en) 2017-02-27 2022-07-05 Third Pole, Inc. Systems and methods for generating nitric oxide
US11911566B2 (en) 2017-02-27 2024-02-27 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US10328228B2 (en) 2017-02-27 2019-06-25 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US11833309B2 (en) 2017-02-27 2023-12-05 Third Pole, Inc. Systems and methods for generating nitric oxide
US10532176B2 (en) 2017-02-27 2020-01-14 Third Pole, Inc. Systems and methods for generating nitric oxide
US11524134B2 (en) 2017-02-27 2022-12-13 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US11554240B2 (en) 2017-02-27 2023-01-17 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
US11478594B2 (en) 2018-05-14 2022-10-25 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection
US11045620B2 (en) 2019-05-15 2021-06-29 Third Pole, Inc. Electrodes for nitric oxide generation
US11478601B2 (en) 2019-05-15 2022-10-25 Third Pole, Inc. Electrodes for nitric oxide generation
US11479464B2 (en) 2019-05-15 2022-10-25 Third Pole, Inc. Systems and methods for generating nitric oxide
US20200359966A1 (en) * 2019-05-17 2020-11-19 Gyrus Acmi, Inc. Collateral ventilation assessment system
US11324954B2 (en) 2019-06-28 2022-05-10 Covidien Lp Achieving smooth breathing by modified bilateral phrenic nerve pacing
US11691879B2 (en) 2020-01-11 2023-07-04 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
US11827989B2 (en) 2020-06-18 2023-11-28 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022241416A1 (en) * 2021-05-13 2022-11-17 Penland Foundation Treatment of ards and other conditions caused by acutely elevated cytokine levels and post ards chronic cytokine production using inhaled anesthetics

Also Published As

Publication number Publication date
JP2001517108A (en) 2001-10-02
CA2278053A1 (en) 1998-07-23
PT973443E (en) 2006-08-31
WO1998031282A1 (en) 1998-07-23
CA2278053C (en) 2010-03-23
EP0973443A1 (en) 2000-01-26
DE59813457D1 (en) 2006-05-11
AU5863898A (en) 1998-08-07
ES2262220T3 (en) 2006-11-16
US7861717B1 (en) 2011-01-04
ATE320829T1 (en) 2006-04-15
EP0973443B1 (en) 2006-03-22
DK0973443T3 (en) 2006-07-24

Similar Documents

Publication Publication Date Title
US7861717B1 (en) Controlled gas-supply system
US20200163989A1 (en) System And Method Of Administering A Pharmaceutical Gas To A Patient
EP3479862A1 (en) Method for inhalation effect on the body, and apparatus for implementing same
AU2014201260B2 (en) System and method of administering a pharmaceutical gas to a patient
AU2015201474B2 (en) System and method of administering a pharmaceutical gas to a patient
AU2018229527A1 (en) System and method of administering a pharmaceutical gas to a patient
MX2008003829A (en) System and method of administering a pharmaceutical gas to a patient

Legal Events

Date Code Title Description
AS Assignment

Owner name: INO THERAPEUTICS GMBH, AUSTRIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MESSER GRIESHEIM GMBH (NEW BY CHANGE OF NAME, MESSER AUSTRIA GMBH);REEL/FRAME:013290/0892

Effective date: 20020924

AS Assignment

Owner name: INO THERAPEUTICS GMBH, AUSTRIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MESSER GRIESHEIM GMBH (NOW BY CHANGE OF NAME, MESSER AUSTRIA GMBH);REEL/FRAME:013478/0189

Effective date: 20020924

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION